Retour sur lavenir.net
   AGFA-GEVAERT 0.420 € (-1,52 %)     UCB 252.400 € (+0,96 %)     BANQUP GROUP 1.880 € (+10,59 %)     KBC ANCORA 82.600 € (+2,48 %)     AZELIS GROUP 10.030 € (-1,28 %)     UMICORE 23.940 € (-0,25 %)     SOFINA 223.200 € (+1,64 %)     JENSEN-GROUP 83.600 € (-0,48 %)     SIPEF 92.900 € (-0,11 %)     TUBIZE-FIN 221.000 € (+1,56 %)     BPOST 1.642 € (-1,79 %)     VIOHALCO 19.300 € (+0,21 %)     FLUXYS BELGIUM D 19.850 € (+1,28 %)     RECTICEL 10.600 € (-1,12 %)     ONWARD MEDICAL 2.670 € (+1,52 %)     XIOR 26.000 € (-0,57 %)     RETAIL ESTATES 69.500 € (0,00 %)     CENERGY 23.740 € (-3,02 %)     ENERGYVISION 14.720 € (-0,27 %)     BREDERODE 103.200 € (-0,58 %)     CARE PROPERTY INV. 12.380 € (-0,48 %)     IMMOBEL 23.000 € (+5,99 %)     PROXIMUS 6.260 € (-1,96 %)     GBL 78.900 € (-0,44 %)     AGEAS 67.750 € (+0,44 %)     HYBRID SOFTWARE GR 4.000 € (+0,50 %)     GIMV 45.050 € (-0,11 %)     KBC 119.850 € (+1,78 %)     WDP 21.760 € (-1,09 %)     D'IETEREN GROUP 167.400 € (-0,36 %)     CAMPINE 229.000 € (+0,44 %)     WERELDHAVE BELGIUM 52.400 € (+0,38 %)     BEKAERT 42.500 € (+0,12 %)     TITAN S.A. 53.500 € (+1,23 %)     SOLVAY 27.640 € (+1,25 %)     ELIA GROUP 133.600 € (-0,22 %)     BARCO 8.645 € (+0,58 %)     EVS 29.800 € (0,00 %)     DECEUNINCK 2.330 € (+0,65 %)     VASTNED 29.500 € (-0,17 %)     QUESTFOR GR-PRICAF 2.974 € (-1,51 %)     TINC 11.700 € (-0,34 %)     COFINIMMO 81.150 € (-0,55 %)     SYENSQO 68.800 € (+1,25 %)     ACKERMANS V.HAAREN 287.200 € (+0,77 %)     SHURGARD 23.950 € (-0,83 %)     COLRUYT 35.000 € (+1,86 %)     IBA 16.720 € (+4,24 %)     TESSENDERLO 20.600 € (+1,48 %)     ONTEX GROUP 2.420 € (-2,42 %)     DEME GROUP 184.800 € (-0,22 %)     KINEPOLIS GROUP 35.300 € (-0,70 %)     AB INBEV 70.600 € (-0,81 %)     AEDIFICA 69.050 € (-0,29 %)     VAN DE VELDE 30.400 € (+0,33 %)     CIE BOIS SAUVAGE 306.000 € (0,00 %)     NYXOAH 1.468 € (+5,01 %)     ASCENCIO 51.700 € (-2,08 %)     HOME INVEST BE. 19.480 € (-0,61 %)     CFE 12.800 € (+2,40 %)  
   TOTALENERGIES 72.210 € (-1,15 %)     SOITEC 124.700 € (-3,07 %)     KERING 264.900 € (-0,17 %)     ROBERTET 812.000 € (-1,46 %)     SHELL PLC 35.110 € (-1,10 %)     AEGON 7.468 € (-0,27 %)     ENGIE 26.960 € (+0,22 %)     BASIC-FIT 31.800 € (-0,81 %)     EIFFAGE 130.250 € (+0,70 %)     AYVENS 11.900 € (-1,41 %)     EUTELSAT COMMUNIC. 2.554 € (-1,39 %)     WOLTERS KLUWER 59.800 € (-0,23 %)     LEGRAND 145.000 € (+4,54 %)     FLOW TRADERS 25.940 € (+0,39 %)     ABIVAX 88.300 € (+5,69 %)     ESSILORLUXOTTICA 174.750 € (-4,79 %)     ATOS 36.400 € (-0,66 %)     ASML HOLDING 1 656.400 € (+4,10 %)     BOIRON 27.500 € (-0,72 %)     AXA 42.530 € (+0,43 %)     ADYEN 888.300 € (-0,22 %)     THX PHARMA 3.720 € (-5,58 %)     GETLINK SE 18.570 € (+0,05 %)     AKZO NOBEL 59.000 € (+0,68 %)     VINCI 130.300 € (+0,85 %)     UMG 18.630 € (+2,93 %)     FUGRO 11.350 € (+2,44 %)     APERAM 48.980 € (-2,33 %)     SMCP 5.145 € (-0,19 %)     NEXITY 7.800 € (+0,71 %)     SAFRAN 324.000 € (0,00 %)     PERNOD RICARD 62.520 € (-1,39 %)     MEDINCELL 24.640 € (-12,06 %)     MICHELIN 33.320 € (-1,24 %)     SANOFI 74.880 € (-1,03 %)     TIKEHAU CAPITAL 17.640 € (-1,89 %)     2CRSI 44.600 € (-2,58 %)     STMICROELECTRONICS 65.160 € (-0,79 %)     CBI 0.109 € (+6,86 %)     RELX 28.360 € (+0,93 %)     S.E.B. 53.100 € (-2,75 %)     LVMH 511.000 € (-1,79 %)     DASSAULT SYSTEMES 17.315 € (-0,29 %)     ASM INTERNATIONAL 1 046.000 € (+5,89 %)     GL EVENTS 32.950 € (-0,90 %)     AMG 36.700 € (+2,86 %)     CHRISTIAN DIOR 474.400 € (-1,33 %)     X-FAB 9.580 € (-2,15 %)     GECINA 73.500 € (-1,01 %)     AHOLD DEL 35.390 € (-2,26 %)     AIRBUS 187.020 € (+0,93 %)     STELLANTIS NV 5.781 € (-3,21 %)     MEDIANTECHNOLOGIES 5.240 € (+2,75 %)     ACCOR 48.150 € (-0,72 %)     PLUXEE 11.380 € (+1,34 %)     CROSSJECT 1.896 € (-0,11 %)     ALTAREA 96.800 € (+0,31 %)     L'OREAL 382.150 € (-1,04 %)     INPOST 15.310 € (-0,07 %)     LHYFE 2.000 € (-0,99 %)  
AIR LIQUIDE
AI - FR0000120073 - Euronext Paris
166,900 €  17:35
-0,29 %
17/06/2026 08:45

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home

PRESS RELEASE

Paris, June 17, 2026

Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home

The Valencia province, in Spain, has selected Air Liquide to support over 90,000 patients living with respiratory conditions at home. The Spanish autonomous regional governments are responsible for organizing healthcare resources and designing the outsourcing of these services. This milestone four-year contract, covering 11 Health Departments, stood out for Air Liquide’s operational excellence and the effectiveness of its cutting-edge digital and Artificial Intelligence (AI) solutions. The Group’s advanced services and solutions are designed to personalize care and ensure treatment adherence in order to improve patient health outcomes and quality of life at home, while preserving the sustainability of healthcare systems in a context of rising chronic diseases.

With this contract, Air Liquide will provide care for people living with respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and sleep apnea, by offering personalized care plans with special monitoring for highly dependent individuals.

Driven by a commitment to innovation, Air Liquide’s solution introduces continuous telemonitoring from the very beginning of patient care for 100% of patients. By integrating predictive AI algorithms, the system aims to identify sleep apnea patients at high risk of non-adherence within the first week. This allows for reinforced human support care plans to the patients who need it most. Air Liquide’s teams prioritize non-compliant patients and, in coordination with physicians, adapt the intervention efforts. This strategic combination of human expertise and digital resources enables real-time care adaptation, in order to improve adherence while easing pressure on healthcare systems. The deployment also includes MaskMate®, an Air Liquide app, for personalized mask selection and specific clinical protocols for high-risk conditions like Obesity Hypoventilation Syndrome (OHS).

Patients and healthcare professionals will benefit from the expertise of a multidisciplinary team of professionals - including technicians, doctors, nurses, and social workers - working in strong coordination with prescribing departments. The Air Liquide Spanish team's unwavering support and commitment were recently demonstrated during critical crisis events, including the 2024 DANA floods and the 2025 Iberian Peninsula power blackout.

Diana Schillag, member of Air Liquide's Executive Committee, overseeing Healthcare activity, stated: "This new contract in the Valencia province is a further illustration of our ability to provide innovative healthcare services to patients at home, in close coordination with healthcare professionals. By leveraging pioneering AI solutions, we contribute to design efficient and streamlined care pathways that aim to deliver the best outcomes. In addition to the human support of our teams, our innovations help reduce administrative burdens, improve operational performance, and, most importantly, save valuable time for both patients and doctors. By managing growing patient volumes while delivering the right level of care, we contribute to the affordability of therapy solutions, the integration of preventive care for patients with chronic diseases, as well as the efficiency and sustainability of healthcare systems.”

About Air Liquide Healthcare

Air Liquide Healthcare is a world leader in home healthcare services, medical gases and specialty ingredients. Our 15,000 employees support 2.3 million chronic patients and provide medical gases and related services to 20,000 hospitals and care facilities, as well as to 110,000 healthcare professionals customers. Committed to working alongside professionals and health institutions, our approach is based on the principles of value in Healthcare, which aims to improve the benefits experienced by patients and to facilitate the work of caregivers, at the best cost for society, thus contributing to a more efficient and sustainable system.

In Spain, Air Liquide accompanies 650,000 patients with a growing presence over the last 30 years.

www.airliquide.com

Follow Air Liquide on LinkedIn

CONTACTS

Corporate Communications
media@airliquide.com

Investor Relations
IRTeam@airliquide.com

Oxygen, nitrogen, hydrogen, and many other essential small molecules are the invisible pillars of our world and our lives. They have been at the core of the Group’s activities since its creation in 1902.

A world leader in gases, technologies and services for industry and healthcare, Air Liquide acts as the backbone of numerous economic sectors, serving 4.3 million customers and patients across 59 countries with approximately 65,000 employees. With revenues close to 27 billion euros in 2025, Air Liquide combines strong performance and useful growth.

The Group is a leader with a diversified, resilient business model and a strong local footprint across the globe. Through deep engineering expertise and technological innovation, Air Liquide provides scalable solutions that enhance industrial efficiency, accelerate decarbonization, and strengthen value chains. Strategically exposed to growth markets and megatrends, the Group accompanies major industrial and societal transformations to create long term added value and build a sustainable future.

Air Liquide is listed on the Euronext Paris stock exchange (compartment A) and belongs to the CAC 40, CAC 40 ESG, EURO STOXX 50, FTSE4Good, and Dow Jones Best-in-Class Europe Index indexes. .

Follow us | www.airliquide.com | LinkedIn

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière